CHM chimeric therapeutics limited

Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-9

  1. 318 Posts.
    lightbulb Created with Sketch. 229
    Yeah agree. Welcome to the asx. At least some good price action on some of the other cell therapy and bio Coys on the ASX today.

    No doubt CHM will get there with some more data and awareness. Only $4k to get us to 9.6c. It's got your name all over it Theman.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $10.07M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.28K 2.672M

Buyers (Bids)

No. Vol. Price($)
5 2758365 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14960701 24
View Market Depth
Last trade - 15.03pm 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.